Renibus Therapeutics, Inc.

Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Pharmaceutical preparations for the treatment of heart conditions, diseases, and disorders, kidney conditions, diseases, and disorders, liver conditions, disease, and disorders, acute kidney injury (AKI), and cardio-renal conditions, diseases, and disorders; pharmaceutical preparations for treatment of patients following cardiothoracic surgery; anti-inflammatories; pharmaceutical preparations for preventing progression of metabolic diseases and conditions, namely, chronic kidney disease, cardiovascular, pulmonary, and metabolic conditions; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for reducing metabolic acidosis

Pharmaceutical preparations for the treatment of heart conditions, diseases, and disorders, kidney conditions, diseases, and disorders, liver conditions, disease, and disorders, acute kidney injury (AKI), and cardio-renal conditions, diseases, and disorders; pharmaceutical preparations for treatment of patients following cardiothoracic surgery; anti-inflammatories; pharmaceutical preparations for preventing progression of metabolic diseases and conditions, namely, chronic kidney disease, cardiovascular, pulmonary, and metabolic conditions; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for reducing metabolic acidosis

Pharmaceutical preparations for the treatment of heart conditions, diseases, and disorders, kidney conditions, diseases, and disorders, liver conditions, disease, and disorders, acute kidney injury (AKI), and cardio-renal conditions, diseases, and disorders; pharmaceutical preparations for treatment of patients following cardiothoracic surgery; anti-inflammatories; pharmaceutical preparations for preventing progression of metabolic diseases and conditions, namely, chronic kidney disease, cardiovascular, pulmonary, and metabolic conditions; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for reducing metabolic acidosis; "THERAPEUTICS"

"THERAPEUTICS"

Pharmaceutical preparations for the treatment of heart disease, kidney disease, liver disease, and acute kidney injury (AKI); "THERAPEUTICS"